entertainment -WSS

entertainment

author：comprehensive 2025-08-29 01:53:33 - browse：4993

A team of high-powered scientists and billionaire investors said Friday that they’re launching a biomedical institute in Cambridge’s Kendall Square with $500 million in private funding with the aim of shortening the path from research breakthroughs to life-saving medicines.

The institute, called Arena BioWorks, will put drug discovery and company creation under one roof, upending the traditional model where academic research and venture-backed drug development are separate.

Backed by deep-pocketed investors including Steve Pagliuca, the former co-chair of Bain Capital and Celtics co-owner, and high-tech mogul Michael Dell, Arena has already lured top scientists from academic labs with lucrative compensation packages, but so far has publicly named only a few.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： SAMSHA loosens regulations on methadone treatment centers

entertainment

WSS

New Ultima Genomics DNA sequencer can read genome for $100

FDA's Woodcock to retire early next year

FDA's Woodcock to retire early next year

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

focus

entertainment

focus

Jerome Adams on the need for new antivirals for Covid

World's first CRISPR

New air purifier tech could be key to improving indoor air quality

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Dobbs anniversary: the lost opportunity of abortion as health care

General Catalyst, Summa Health deal will turn on physician buy

Continuity nursing helped my family in our darkest PICU moments

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

As demand for Covid shots wanes, Moderna seeks its next success

In key trial, Verve's treatment lowers cholesterol levels in patients

Wikipedia

U.K. considers world's first use of meningitis vaccine to address gonorrhea

The real point of Kenneth Smith’s execution by nitrogen gas

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

David Sabatini, ex

Apple Vision Pro: A first look at health apps on the new VR headset

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

entertainment

entertainment

explore

Wikipedia